Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C-S Chim

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
AJR. American Journal of Roentgenology|May 25, 2001
Radiologic manifestations of granulocytic sarcoma in adult leukemiaG C Ooi, C S Chim, P L Khong, et al.
Blood Cells, Molecules & Diseases|April 2, 2003
Can defects in transferrin receptor 2 and hereditary hemochromatosis genes account for iron overload in HbH disease?Vivian Chan, Man Sim Wong, Clara Ooi, et al.
British Journal of Haematology|June 1, 1997
CD56+ NK lymphomas: clinicopathological features and prognosisY L Kwong, A C Chan, R Liang, et al.
Hematological Oncology|March 5, 1999
Allogeneic bone marrow transplantation for severe aplastic anemia: the Hong Kong scenarioW Y Au, A K Lie, Y L Kwong, et al.
Hematological Oncology|September 1, 1996
All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL)C S Chim, Y L Kwong, R Liang, et al.
Carcinogenesis|February 2, 2010
Epigenetic inactivation of the miR-34a in hematological malignanciesC S Chim, K Y Wong, Y Qi, et al.
Cancer|February 15, 2001
Primary CD56 positive lymphomas of the gastrointestinal tractC S Chim, W Y Au, T W Shek, et al.
Hematology (Amsterdam, Netherlands)|July 31, 2010
Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patientsC S Chim, J P Sim, C C Chan, et al.
Leukemia|March 8, 2019
Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Leukemia|December 20, 2017
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
AJR. American Journal of Roentgenology|May 25, 2001
Radiologic manifestations of granulocytic sarcoma in adult leukemiaG C Ooi, C S Chim, P L Khong, et al.
Blood Cells, Molecules & Diseases|April 2, 2003
Can defects in transferrin receptor 2 and hereditary hemochromatosis genes account for iron overload in HbH disease?Vivian Chan, Man Sim Wong, Clara Ooi, et al.
British Journal of Haematology|June 1, 1997
CD56+ NK lymphomas: clinicopathological features and prognosisY L Kwong, A C Chan, R Liang, et al.
Hematological Oncology|March 5, 1999
Allogeneic bone marrow transplantation for severe aplastic anemia: the Hong Kong scenarioW Y Au, A K Lie, Y L Kwong, et al.
Hematological Oncology|September 1, 1996
All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL)C S Chim, Y L Kwong, R Liang, et al.
Carcinogenesis|February 2, 2010
Epigenetic inactivation of the miR-34a in hematological malignanciesC S Chim, K Y Wong, Y Qi, et al.
Cancer|February 15, 2001
Primary CD56 positive lymphomas of the gastrointestinal tractC S Chim, W Y Au, T W Shek, et al.
Hematology (Amsterdam, Netherlands)|July 31, 2010
Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patientsC S Chim, J P Sim, C C Chan, et al.
Leukemia|March 8, 2019
Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Leukemia|December 20, 2017
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.
Pageof 10